ArabFinance: Arab Drug Company (ADCI) recorded a net profit before tax of EGP 53.55 million during the five-month period ended November 2021, down from EGP 62.67 million in the year-ago period, according to the company’s financial indicators filed to the Egyptian Exchange (EGX).

Moreover, the company generated a net sale of EGP 240.91 million in the July-November period of 2021, compared to EGP 244.63 million in the same period of 2020.

Arab Drug is an Egypt-based company engaged in the pharmaceutical sector. The company focuses on the manufacture, packaging, and distribution of pharmaceutical products as well as chemical solutions for human and veterinary use.